« Return to News | CROs/Service Providers | R&D Trends

BioClinica Revenues Flat in ‘09

Thursday, February 11, 2010 06:28 AM

BioClinica reported its fourth quarter and full-year 2009 earnings earlier this week. Service revenues for the quarter were almost flat from the fourth quarter 2008 at $14.9 million. Income from continuing operations was $943,000, or $0.06 per fully diluted share, compared with income of $1.7 million for the same period 2008.

Service revenues for the full-year were $57.4 million, compared with $56.2 million for the same period 2008. Income from continuing operations, net of taxes was $3 million, or $0.20 per fully diluted share, as compared with $5.8 million, or $0.40 per fully diluted share, for the same period 2008.

“With our strengthened offerings, increased proposal activity and our improved backlog, we expect full-year 2010 service revenue to be in the range of $61 to $65 million,” said president and CEO Mark Weinstein in a statement. Earnings per share are expected to be in the range of $0.25 to $0.29 per share.

 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.